Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

67147 Press Releases
DateTitleCompany
04 Jun 12 Bulwark®, VF's Flame Resistant Workwear Brand, Burns Paper City to Showcase Worker Safety WEBER SHANDWICK,
Published by
PR Newswire
04 Jun 12 Emergent BioSolutions Secures Additional Funding from BARDA to Pursue Post-Exposure Prophylaxis Indication for BioThrax Emergent BioSolutions Inc.,
Published by
Business Wire
04 Jun 12 New Agreements to Give Quintiles Access to De-Identified EMR Data Representing 40 Million Patient Lives Quintiles,
Published by
Business Wire
04 Jun 12 AVEO and Astellas Announce TAURUS Patient Preference Clinical Study Comparing Tivozanib with Sunitinib in First-Line Kidney Cancer AVEO Oncology,
Published by
Business Wire
04 Jun 12 LabCorp Announces Agreement to Acquire MEDTOX Scientific Laboratory Corporation of America(R) Holdings,
Published by
Business Wire
04 Jun 12 Polynoma Commences Phase III Melanoma Vaccine Clinical Trial Polynoma LLC,
Published by
Business Wire
04 Jun 12 Simulations Plus Reports Preliminary Third Quarter FY2012 Results Simulations Plus Inc.,
Published by
Business Wire
04 Jun 12 Codexis Appoints John J. Nicols as President and Chief Executive Officer Codexis Inc.,
Published by
Business Wire
04 Jun 12 ARIAD Announces Updated Data from Pivotal PACE Trial of Ponatinib, Its Investigational pan-BCR-ABL Inhibitor ARIAD Pharmaceuticals Inc.,
Published by
Business Wire
04 Jun 12 SentreHEART Secures $26 Million in Series C Financing for Commercialization SentreHEART Inc.,
Published by
Business Wire
04 Jun 12 CytRx to Hold Conference Call Today at 10:00 a.m. Eastern Time to Discuss Favorable Results from INNO-206 Clinical Trial in Soft Tissue Sarcoma CytRx Corporation,
Published by
Business Wire
04 Jun 12 Hi-Tech Pharmacal Acquires Rights to the Cormax® Brand for its ECR Pharmaceuticals Subsidiary Hi-Tech Pharmacal Co. Inc.,
Published by
Business Wire
04 Jun 12 Senesco Provides SNS01-T Update on Phase 1b/2a Multiple Myeloma Trial Senesco Technologies Inc.,
Published by
Business Wire
04 Jun 12 Univita Health Appoints Jean Haynes President and Chief Executive Officer Univita Health,
Published by
Business Wire
04 Jun 12 Formula Pharmaceuticals Appoints Morton Collins to Board of Directors Formula Pharmaceuticals Inc.,
Published by
Business Wire
04 Jun 12 Oklahoma Bioscience Association to Exhibit at 2012 BIO International Convention, booth 809, Jun 18 - 21, 2012, in Boston MA, US Oklahoma Bioscience Association,
Published by
Business Wire
04 Jun 12 UAE triumphs at 2012 Hospital Build Awards in Dubai Informa Life Sciences Exhibitions
04 Jun 12 /R E P E A T -- Important ZYTIGA® Prostate Cancer Data Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting/ Janssen Inc.,
Published by
PR Newswire
04 Jun 12 TRICAST Heads Into 15th Year With Continued Strong Growth ERELEASES,
Published by
PR Newswire
04 Jun 12 Lando & Anastasi, LLP Expands Biotechnology/Pharmaceutical and Electrical/Computer Patent Teams Lando and Anastasi LLP,
Published by
Business Wire
04 Jun 12 Quality Systems, Inc. Included in Forbes’ Annual List of America’s 25 Fastest-Growing Tech Companies Quality Systems,
Published by
Business Wire
04 Jun 12 MARIJUANA, INC. Changes Its Name To Hemp, Inc. MACREPORTMEDIA.COM,
Published by
PR Newswire
04 Jun 12 EpiCept Corporation Receives Scientific Advice from European Medicines Agency for AmiKet™ CIPN Program EpiCept Corporation,
Published by
Business Wire
04 Jun 12 ImmunoGen, Inc. Announces Presentation of New Clinical Data for SAR3419 ImmunoGen Inc.,
Published by
Business Wire
04 Jun 12 ImmunoGen, Inc. Announces Development of Trastuzumab Emtansine for Early Stage HER2-Positive Breast Cancer ImmunoGen Inc.,
Published by
Business Wire
03 Jun 12 ASCO Presentations Highlight Preliminary Results of Studies with MLN9708, First Oral Proteasome Inhibitor in Clinical Trials in Multiple Myeloma Millennium: The Takeda Oncology Company,
Published by
Business Wire
03 Jun 12 CytRx Announces Favorable Results from Phase 1b/2 Clinical Trial with INNO-206 CytRx Corporation,
Published by
Business Wire
03 Jun 12 Advaxis to Report Updated Safety, Tumor Response, and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer at ASCO Advaxis Inc.,
Published by
Business Wire
03 Jun 12 Genentech Data Showed That People With Metastatic Colorectal Cancer Lived Longer When They Continued on Avastin Plus Chemotherapy Genentech,
Published by
Business Wire
03 Jun 12 Genentech’s Targeted Investigational Breast Cancer Medicine, Trastuzumab Emtansine (T-DM1), Reduced the Risk of Cancer Worsening or Death by 35 Percent in Pivotal Phase III Trial Genentech,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.